Bayers

Bayer’s Monsanto Unit Receives $1 Billion Reduction in Roundup Cancer Verdict, Providing Relief Amidst Legal Battles

by

JEFFERSON CITY, Missouri – A judge in Missouri has reduced a $1.5 billion jury verdict against Bayer AG’s Monsanto unit by nearly $1 billion, marking a significant victory for the company in its ongoing legal battle over the cancer risks associated with its Roundup weedkiller. Judge Daniel Green refused to grant Monsanto’s requests for a new trial or to dismiss the entire verdict, but he did reduce the punitive damages portion of the award by over 60% to approximately $550 million. This reduction in the Missouri award comes as a relief for Bayer, which has … Read more

Bayer’s Multimillion-Dollar Roundup Verdict Significantly Reduced, But Controversy Looms

by

SAN FRANCISCO, California – In a landmark decision, a California judge has dramatically reduced the verdict against Bayer regarding their Roundup weedkiller. The company was originally ordered to pay $332 million in damages to a couple who claimed that the product caused them to develop cancer. However, the judge has now slashed the verdict by over 90%. The case involved Alva and Alberta Pilliod, a couple who used Roundup for more than three decades. They alleged that their exposure to the herbicide caused them both to develop non-Hodgkin’s lymphoma. Last year, a jury sided with … Read more

Landmark Victories for Roundup Lawsuit Plaintiffs Suggest a Troubling Trend for Bayer’s Future

by

San Francisco, CA – The legal battle between Bayer and plaintiffs continues to escalate as another victory for Roundup lawsuit plaintiffs emerged. Recent verdicts have been a cause for concern for the pharmaceutical company, as they indicate a favorable trend for the plaintiffs. Nora Freeman Engstrom, a professor specializing in mass tort actions at Stanford Law, suggests that these outcomes may further strengthen the cases against Bayer, as previous statements made in testimony can be used by plaintiffs’ lawyers to build a compelling argument over time. Bayer finds itself facing mounting legal challenges related to … Read more

Bayer’s Roundup Settlements Soar as Glyphosate Controversy Rages On

by

Los Angeles, CA – Bayer, the pharmaceutical company that acquired Roundup brands as part of its purchase of Monsanto, has announced a $2 billion settlement to cover future claims related to the controversial weedkiller. The settlement comes after years of legal battles over the chemical glyphosate, the active ingredient in Roundup. Glyphosate has been at the center of controversy due to differing opinions on its safety. In 2015, the World Health Organization’s cancer research agency concluded that glyphosate was probably carcinogenic to humans. However, many regulatory agencies, including the U.S. EPA, classify the chemical as … Read more